Since HLA-DR mediated antigen presentation is critical for priming CD4+ T cell effector functions, HLA-DR can also be considered to be an integral, upstream part of this anti-carcinoma, TH1 axis, suggesting that future studies may benefit from inclusion of HLA-DR into prognostic scoring panels. This evidence concerns the gene CD4 and carcinoma.